MedTech Acquisition Corp (MTAC) Peer Comparison
$11.34
As on 10-Aug-2023 16:00EDT
Market cap
$84 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
226.8
P/B Ratio
1.3
Div. Yield
0 %
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
Market cap ($ Mln) |
84 | 116 |
Revenue ($ Mln) |
-- | -- |
Net Profit ($ Mln) |
-1.13 | 5.61 |
Net Margin (%) |
-31.78 | 92.08 |
RoE (%) |
-- | 4.15 |
Price to Earnings |
226.80 | -- |
Price-To-Book |
1.31 | -- |
Income Statement ($ Mln)
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Operating Revenue
|
0.00 | 0.00 |
|
Cost of Revenue
|
-- | -- |
|
Gross Profit
|
-- | -- |
|
Operating Expenses
|
2.75 | 1.93 |
|
Operating Profit (EBIT)
|
-2.75 | -1.93 |
|
Other Income
|
8.86 | 16.10 |
|
Profit before Tax
|
6.11 | 14.42 |
|
Provision for Tax
|
0.57 | 0.68 |
|
Profit after Tax (Net Income)
|
5.54 | 13.73 |
|
Minority Interest
|
-- | -- |
|
Consolidated Profit
|
5.54 | 27.46 |
Liabilities ($ Mln)
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Shareholder's Funds
|
6.53 | 234.66 |
|
Minority Interest
|
-- | -- |
|
Non-Current Liabilities
|
11.15 | 0.32 |
|
Current Liabilities
|
2.50 | 2.12 |
|
Total Liabilities
|
20.19 | 237.10 |
Assets ($ Mln)
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Non-Current Assets
|
19.83 | 236.94 |
|
Current Assets
|
0.36 | 0.16 |
|
Total Assets
|
20.19 | 237.10 |
|
Total Debt*
|
2.37 | 0.74 |
|
Net Current Assets
|
-2.14 | -1.96 |
Cashflow ($ Mln)
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Cash From Operating Activities
|
-2.74 | -0.94 |
|
Cash Flow from Investing Activities
|
233.20 | -233.45 |
|
Cash from Financing Activities
|
-230.51 | 0.60 |
|
Net Cash Inflow / Outflow
|
-0.05 | -233.78 |
Ratios
Profitability Ratios
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
ROCE (%)
|
4.56 | 6.12 |
|
ROE (%)
|
4.62 | 6.13 |
|
ROA (%)
|
4.09 | 5.83 |
|
EBIT Margin (%)
|
-- | -- |
|
Net Margin (%)
|
62.55 | 85.30 |
|
Cash Profit Margin (%)
|
-- | -- |
Growth Ratios
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Revenue Growth (%)
|
-- | -- |
|
EBIT Growth (%)
|
-- | -- |
|
Net Profit Growth (%)
|
16.19 | 1,601.21 |
|
EPS Growth (%)
|
-- | -- |
|
Book Value Growth (%)
|
-- | -- |
Valuation Ratios
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Price / Earnings
|
-- | -- |
|
Price / Book Value
|
-- | -- |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
2.05 | -0.04 |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Debt to Equity
|
0.36 | 0.00 |
|
Short term debt to equity ratio
|
0.16 | 0.00 |
|
Current Ratio
|
0.14 | 0.07 |
|
Quick Ratio
|
-- | -- |
|
Interest Coverage
|
-0.31 | -0.12 |
Operating Efficiency Ratios
| MedTech Acquisition Corp (MTAC) | Mercato Partners Acquisition Corp (MPRA) | |
|---|---|---|
|
Debtors to sales (%)
|
-- | -- |
|
Asset Turnover
|
0.00 | 0.00 |
|
Receivable days
|
-- | -- |
|
Inventory Days
|
-- | -- |
|
Payable days
|
-- | -- |
|
Cash Conversion Cycle
|
-- | -- |